{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:32:45Z","timestamp":1787283165618,"version":"build-2736575974"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pentraxins, which constitute a family of evolutionarily conserved pattern recognition molecules, are categorized into short and long branches. The long pentraxin 3 (PTX3) is a key member of the long pentraxin subfamily, while the C-reactive protein and serum amyloid P represent the short pentraxins. All pentraxins share a highly conserved C-terminal motif, an 8-amino acid sequence known as the pentraxin signature. PTX3 can be produced by a wide range of cell types, including immune cells such as dendritic cells, monocytes, and macrophages, as well as various non-immune cells, underscoring its pleiotropic roles in multiple pathophysiological processes. These include inflammation, infection, tissue repair, female fertility, and cancer. Although PTX3 engages commonly recognized signaling pathways, such as TNF-\u03b1, NF-\u03baB, FGF, and PI3K\/AKT, it can exert paradoxical effects in different cellular contexts, either promoting or inhibiting the proliferation, migration, invasion, and metastasis of cancer cells. This review provides a comprehensive overview of the multifaceted roles of PTX3 in various cancers, while also summarizing its functions in other physiological or pathological contexts. Furthermore, we critically examine the challenges and translational opportunities of PTX3, aiming to inform future research directions and therapeutic strategies for cancer management.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1705051","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:20:27Z","timestamp":1765948827000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["The long pentraxin 3: the invisible loom weaving the warp and weft of tumor destiny"],"prefix":"10.3389","volume":"16","author":[{"given":"Tianyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuenan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901672","article-title":"Evolution of the pentraxin family: the new entry PTX4","volume":"184","author":"Martinez de la Torre","year":"2010","journal-title":"J Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)41653-5","article-title":"Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component","volume":"267","author":"Breviario","year":"1992","journal-title":"J Biol Chem"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1005557","article-title":"The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility","volume":"79","author":"Bottazzi","year":"2006","journal-title":"J Leukoc Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2016.1166957","article-title":"Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsis","volume":"12","author":"Ketter","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00712","article-title":"The long pentraxin PTX3 as a link between innate immunity, tissue remodeling, and cancer","volume":"10","author":"Doni","year":"2019","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00016.2017","article-title":"PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer","volume":"98","author":"Garlanda","year":"2018","journal-title":"Physiol Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115756","article-title":"Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility","volume":"23","author":"Garlanda","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.5.1862.1862","article-title":"Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites","volume":"87","author":"Introna","year":"1996","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ386","article-title":"PTX3 polymorphisms and invasive mold infections after solid organ transplant","volume":"61","author":"W\u00f3jtowicz","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix749","article-title":"Pentraxin 3 gene polymorphisms and pulmonary aspergillosis in chronic obstructive pulmonary disease patients","volume":"66","author":"He","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00926-w","article-title":"Association of polymorphisms in long pentraxin 3 and its plasma levels with COVID-19 severity","volume":"23","author":"Feitosa","year":"2023","journal-title":"Clin Exp Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1672485","article-title":"Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3","volume":"16","author":"Kratzer","year":"2025","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13228","article-title":"PTX3 gene polymorphism associated with cryptococcosis in HIV-uninfected Chinese patients","volume":"64","author":"Zhang","year":"2021","journal-title":"Mycoses"},{"key":"B14","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1186\/s12879-023-08862-0","article-title":"Association of PTX3 gene polymorphisms and PTX3 plasma levels with leprosy susceptibility","volume":"23","author":"Moraes","year":"2023","journal-title":"BMC Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00403-024-03444-9","article-title":"A study of granulysin and pentraxin 3 genetic polymorphisms and their contribution to acne susceptibility","volume":"316","author":"Rizk","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202112-2771OC","article-title":"Pentraxin 3 inhibits complement-driven macrophage activation to restrain granuloma formation in sarcoidosis","volume":"206","author":"Gon\u00e7ales","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201204-0692OC","article-title":"Variation in PTX3 is associated with primary graft dysfunction after lung transplantation","volume":"186","author":"Diamond","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.57886","article-title":"Impact of pentraxin 3 genetic variants on uterine cervical cancer clinicopathologic characteristics","volume":"18","author":"Sun","year":"2021","journal-title":"Int J Med Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature01195","article-title":"Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response","volume":"420","author":"Garlanda","year":"2002","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/1359-6101(96)00019-6","article-title":"Long pentraxins: an emerging group of proteins with diverse functions","volume":"7","author":"Goodman","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(03)00030-9","article-title":"Recognition and clearance of apoptotic cells: a role for complement and pentraxins","volume":"24","author":"Nauta","year":"2003","journal-title":"Trends Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.52.32817","article-title":"Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component","volume":"272","author":"Bottazzi","year":"1997","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01750","article-title":"Regulation of the complement system by pentraxins","volume":"10","author":"Haapasalo","year":"2019","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708535200","article-title":"Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization","volume":"283","author":"Inforzato","year":"2008","journal-title":"J Biol Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/bi0607453","article-title":"Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation","volume":"45","author":"Inforzato","year":"2006","journal-title":"Biochemistry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e2208144119","DOI":"10.1073\/pnas.2208144119","article-title":"PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation","volume":"119","author":"Noone","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00061.x","article-title":"Role of the soluble pattern recognition receptor PTX3 in vascular biology","volume":"11","author":"Presta","year":"2007","journal-title":"J Cell Mol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.085639","article-title":"The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2","volume":"285","author":"Inforzato","year":"2010","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i37.4225","article-title":"Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma","volume":"17","author":"Wang","year":"2011","journal-title":"World J Gastroenterol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.004","article-title":"PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer","volume":"160","author":"Bonavita","year":"2015","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2016.08.010","article-title":"Pentraxin 3 (PTX3) promoter methylation associated with PTX3 plasma levels and neutrophil to lymphocyte ratio in coronary artery disease","volume":"13","author":"Guo","year":"2016","journal-title":"J Geriatr Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1333215","DOI":"10.1080\/2162402X.2017.1333215","article-title":"Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer","volume":"6","author":"Rubino","year":"2017","journal-title":"Oncoimmunology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41467-022-28657-2","article-title":"Menin directs regionalized decidual transformation through epigenetically setting PTX3 to balance FGF and BMP signaling","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8030065","article-title":"Identification of aberrantly-expressed long non-coding RNAs in osteoblastic cells from osteoporotic patients","volume":"8","author":"Centofanti","year":"2020","journal-title":"Biomedicines"},{"key":"B35","doi-asserted-by":"publisher","first-page":"118542","DOI":"10.1016\/j.envpol.2021.118542","article-title":"LncRNA MEG3 alleviates PFOS induced placental cell growth inhibition through its derived miR-770 targeting PTX3","volume":"293","author":"Li","year":"2022","journal-title":"Environ pollut"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1002\/ctm2.227","article-title":"Long noncoding RNA repressor of adipogenesis negatively regulates the adipogenic differentiation of mesenchymal stem cells through the hnRNP A1-PTX3-ERK axis","volume":"10","author":"Pan","year":"2020","journal-title":"Clin Transl Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaab070","article-title":"Expression profiling and function analysis identified new microRNAs regulating cumulus expansion and apoptosis in cumulus cells","volume":"28","author":"Han","year":"2022","journal-title":"Mol Hum Reprod"},{"key":"B38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12885-017-3198-4","article-title":"Simultaneous analysis of miRNA-mRNA in human meningiomas by integrating transcriptome: A relationship between PTX3 and miR-29c","volume":"17","author":"Dalan","year":"2017","journal-title":"BMC Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jacbts.2018.10.006","article-title":"miR-29b Mediates the Chronic Inflammatory Response in Radiotherapy-Induced Vascular Disease","volume":"4","author":"Eken","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225343","article-title":"NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritis","volume":"83","author":"Liu","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7328","DOI":"10.1038\/s41467-023-43219-w","article-title":"RNA m(6)A methylation modulates airway inflammation in allergic asthma via PTX3-dependent macrophage homeostasis","volume":"14","author":"Han","year":"2023","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12920-025-02104-9","article-title":"m6A regulator-based molecular classification and hub genes associated with immune infiltration characteristics and clinical outcomes in diffuse gliomas","volume":"18","author":"Lu","year":"2025","journal-title":"BMC Med Genomics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e30671","DOI":"10.1002\/pbc.30671","article-title":"Clinical and transcriptomic characteristics of a novel SMARCD2 mutation that disrupts neutrophil maturation and function","volume":"70","author":"Dotta","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3812","article-title":"SMARCD2 subunit of SWI\/SNF chromatin-remodeling complexes mediates granulopoiesis through a CEBP\u03b5 dependent mechanism","volume":"49","author":"Priam","year":"2017","journal-title":"Nat Genet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"102979","DOI":"10.1016\/j.jaut.2022.102979","article-title":"The complement system and human autoimmune diseases","volume":"137","author":"Coss","year":"2023","journal-title":"J Autoimmun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00461","article-title":"Interaction of C1q with pentraxin 3 and igM revisited: mutational studies with recombinant C1q variants","volume":"10","author":"Bally","year":"2019","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1021\/bi052646f","article-title":"Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains","volume":"45","author":"Roumenina","year":"2006","journal-title":"Biochemistry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement-MBL and beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100180","article-title":"M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules","volume":"186","author":"Gout","year":"2011","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.009225","article-title":"Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition","volume":"284","author":"Ma","year":"2009","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.smim.2013.05.002","article-title":"PTX3 as a paradigm for the interaction of pentraxins with the complement system","volume":"25","author":"Inforzato","year":"2013","journal-title":"Semin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.154.3.856","article-title":"Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3","volume":"154","author":"Pangburn","year":"1981","journal-title":"J Exp Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01851","article-title":"Be on target: strategies of targeting alternative and lectin pathway components in complement-mediated diseases","volume":"9","author":"Dob\u00f3","year":"2018","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13143","article-title":"Low-molecular weight inhibitors of the alternative complement pathway","volume":"313","author":"Schubart","year":"2023","journal-title":"Immunol Rev"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.04.004","article-title":"Complement factor I in health and disease","volume":"48","author":"Nilsson","year":"2011","journal-title":"Mol Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.591908","article-title":"Control of complement activation by the long pentraxin PTX3: implications in age-related macular degeneration","volume":"11","author":"Stravalaci","year":"2020","journal-title":"Front Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e23991","DOI":"10.1371\/journal.pone.0023991","article-title":"Human pentraxin 3 binds to the complement regulator c4b-binding protein","volume":"6","author":"Braunschweig","year":"2011","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1593\/neo.09934","article-title":"Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice","volume":"11","author":"Margheri","year":"2009","journal-title":"Neoplasia"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0286","article-title":"Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors","volume":"10","author":"Leali","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1137","article-title":"Monoclonal antibody therapy of cancer","volume":"23","author":"Adams","year":"2005","journal-title":"Nat Biotechnol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32638","article-title":"Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers","volume":"146","author":"Nome","year":"2020","journal-title":"Int J Cancer"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1976","article-title":"Chemotherapy-induced upregulation of small extracellular vesicle-associated PTX3 accelerates breast cancer metastasis","volume":"81","author":"Wills","year":"2021","journal-title":"Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2017.11.020","article-title":"Breast osteoblast-like cells: A reliable early marker for bone metastases from breast cancer","volume":"18","author":"Scimeca","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1664","article-title":"Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function","volume":"5","author":"Choi","year":"2014","journal-title":"Oncotarget"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/jog.12495","article-title":"Analyzing the differentially expressed genes and pathway cross-talk in aggressive breast cancer","volume":"41","author":"Chen","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2334-7","article-title":"Breast cancer stem cell: the roles and therapeutic implications","volume":"74","author":"Yang","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aah4674","article-title":"Baldwin AS et\u00a0al: Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers","volume":"10","author":"Thomas","year":"2017","journal-title":"Sci Signal"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00021","article-title":"Scorpion venom analgesic peptide, bmK AGAP inhibits stemness, and epithelial-Mesenchymal transition by down-Regulating PTX3 in breast cancer","volume":"9","author":"Kampo","year":"2019","journal-title":"Front Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1038\/s41467-020-16051-9","article-title":"SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201200526","article-title":"Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer","volume":"13","author":"Pavlou","year":"2013","journal-title":"Proteomics"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/path.4181","article-title":"Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer","volume":"230","author":"Ronca","year":"2013","journal-title":"J Pathol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"297.e219","DOI":"10.1016\/j.urolonc.2019.02.013","article-title":"Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition","volume":"37","author":"Scimeca","year":"2019","journal-title":"Urol Oncol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"18400","DOI":"10.1038\/s41598-020-75376-z","article-title":"Modulation of complement activation by pentraxin-3 in prostate cancer","volume":"10","author":"Stallone","year":"2020","journal-title":"Sci Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0369","article-title":"Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer","volume":"74","author":"Stallone","year":"2014","journal-title":"Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20966","article-title":"Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma","volume":"69","author":"Ravenna","year":"2009","journal-title":"Prostate"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101657","article-title":"(18)F-choline PET\/CT identifies high-grade prostate cancer lesions expressing bone biomarkers","volume":"8","author":"Urbano","year":"2019","journal-title":"J Clin Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"9840962","DOI":"10.1155\/2018\/9840962","article-title":"Prostate osteoblast-like cells: A reliable prognostic marker of bone metastasis in prostate cancer patients","volume":"2018","author":"Scimeca","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4650","article-title":"Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT\/NF-\u03baB signaling pathway","volume":"54","author":"Ahmmed","year":"2019","journal-title":"Int J Oncol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"108818","DOI":"10.1016\/j.abb.2021.108818","article-title":"Pentraxin 3 acts as a functional effector of Akt\/NF-\u03baB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer","volume":"701","author":"Li","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27731","article-title":"Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-\u03baB- and HIF-1\u03b1-mediated downregulation of PTX3","volume":"234","author":"Ahmmed","year":"2019","journal-title":"J Cell Physiol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M900134-MCP200","article-title":"Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines","volume":"8","author":"Planque","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"B84","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1186\/s12885-018-4659-0","article-title":"Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease","volume":"18","author":"Berg","year":"2018","journal-title":"BMC Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"4652483","DOI":"10.1155\/2020\/4652483","article-title":"Pentraxin 3 (PTX-3) levels in bronchoalveolar lavage fluid as a lung cancer biomarker","volume":"2020","author":"Hu","year":"2020","journal-title":"Dis Markers"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-3024","article-title":"Pentraxin-3 is a novel biomarker of lung carcinoma","volume":"17","author":"Diamandis","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29822","article-title":"Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients","volume":"138","author":"Infante","year":"2016","journal-title":"Int J Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12032-014-0207-1","article-title":"Pentraxin-3 as a prognostic marker in patients with small-cell lung cancer","volume":"31","author":"Liu","year":"2014","journal-title":"Med Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.05.158","article-title":"Network-based analysis for identification of candidate genes for colorectal cancer progression","volume":"476","author":"Tsuji","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e0148186","DOI":"10.1371\/journal.pone.0148186","article-title":"Circulating inflammatory mediators as potential prognostic markers of human colorectal cancer","volume":"11","author":"Di Caro","year":"2016","journal-title":"PloS One"},{"key":"B91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1620\/tjem.240.39","article-title":"Increased plasma levels of pentraxin 3 are associated with poor prognosis of colorectal carcinoma patients","volume":"240","author":"Zhang","year":"2016","journal-title":"Tohoku J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e11780","DOI":"10.1097\/MD.0000000000011780","article-title":"Increased serum pentraxin-3 level predicts poor prognosis in patients with colorectal cancer after curative surgery, a cohort study","volume":"97","author":"Liu","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.189921","article-title":"Inhibitory role of pentraxin-3 in esophageal squamous cell carcinoma","volume":"129","author":"Ma","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"5752670","DOI":"10.1155\/2019\/5752670","article-title":"Jie du tong ye san prevents N-nitrosomethylbenzylamine-induced esophageal carcinogenesis via inhibition of inflammation and proliferation","volume":"2019","author":"Zhao","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-14-0003","article-title":"Chemoprevention of esophageal cancer with black raspberries, their component anthocyanins, and a major anthocyanin metabolite, protocatechuic acid","volume":"7","author":"Peiffer","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13510","article-title":"Accumulated promoter methylation as a potential biomarker for esophageal cancer","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.7150\/jca.25188","article-title":"Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition","volume":"9","author":"Song","year":"2018","journal-title":"J Cancer"},{"key":"B98","doi-asserted-by":"publisher","first-page":"20276","DOI":"10.1038\/s41598-020-77332-3","article-title":"Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection","volume":"10","author":"Deng","year":"2020","journal-title":"Sci Rep"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12472","article-title":"Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV","volume":"23","author":"Carmo","year":"2016","journal-title":"J Viral Hepat"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00617-4","article-title":"Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients","volume":"20","author":"Feder","year":"2020","journal-title":"Clin Exp Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10747","article-title":"Upregulation of brain-derived neurotrophic factor in advanced gastric cancer contributes to bone metastatic osteolysis by inducing long pentraxin 3","volume":"7","author":"Choi","year":"2016","journal-title":"Oncotarget"},{"key":"B102","article-title":"Pentraxin-3 silencing suppresses gastric cancer-related inflammation by inhibiting chemotactic migration of macrophages","volume":"35","author":"Choi","year":"2015","journal-title":"Anticancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.7150\/jca.39562","article-title":"Cytokine TNF-\u03b1 promotes invasion and metastasis of gastric cancer by down-regulating Pentraxin3","volume":"11","author":"Cui","year":"2020","journal-title":"J Cancer"},{"key":"B104","doi-asserted-by":"publisher","first-page":"29385","DOI":"10.1038\/srep29385","article-title":"Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells","volume":"6","author":"Ying","year":"2016","journal-title":"Sci Rep"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27370","article-title":"MicroRNA-224 inhibition prevents progression of cervical carcinoma by targeting PTX3","volume":"119","author":"Yu","year":"2018","journal-title":"J Cell Biochem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.RA118.001208","article-title":"Identification of candidate plasma protein biomarkers for cervical cancer using the multiplex proximity extension assay","volume":"18","author":"Berggrund","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0487","article-title":"Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells","volume":"12","author":"Ronca","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091305","article-title":"The autocrine FGF\/FGFR system in both skin and uveal melanoma: FGF trapping as a possible therapeutic approach","volume":"11","author":"Rezzola","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0848-9","article-title":"Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)\/NF-\u03baB signaling pathway","volume":"38","author":"Rathore","year":"2019","journal-title":"Oncogene"},{"key":"B110","doi-asserted-by":"publisher","first-page":"626343","DOI":"10.3389\/fimmu.2020.626343","article-title":"Anti-pentraxin antibodies in autoimmune diseases: bystanders or pathophysiological actors","volume":"11","author":"Brilland","year":"2020","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101305","article-title":"An integrated view of humoral innate immunity: pentraxins as a paradigm","volume":"28","author":"Bottazzi","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coi.2015.11.002","article-title":"PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition","volume":"38","author":"Garlanda","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.02.029","article-title":"The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling","volume":"64","author":"Bottazzi","year":"2016","journal-title":"J Hepatol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1854","article-title":"Regulation of leukocyte recruitment by the long pentraxin PTX3","volume":"11","author":"Deban","year":"2010","journal-title":"Nat Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.02.015","article-title":"The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection","volume":"40","author":"Jaillon","year":"2014","journal-title":"Immunity"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201642","article-title":"Prototypic long pentraxin PTX3 is present in breast milk, spreads in tissues, and protects neonate mice from Pseudomonas aeruginosa lung infection","volume":"191","author":"Jaillon","year":"2013","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e1004649","DOI":"10.1371\/journal.ppat.1004649","article-title":"Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation","volume":"11","author":"Foo","year":"2015","journal-title":"PloS Pathog"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-021-15183-9","article-title":"Increased levels of serum pentraxin 3 in critical coronavirus disease-2019 patients","volume":"29","author":"Moulana","year":"2022","journal-title":"Environ Sci pollut Res Int"},{"key":"B120","doi-asserted-by":"publisher","first-page":"105213","DOI":"10.1016\/j.ebiom.2024.105213","article-title":"The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19","volume":"105","author":"Scavello","year":"2024","journal-title":"EBioMedicine"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043537","article-title":"The prognostic value of pentraxin-3 in COVID-19 patients: A systematic review and meta-analysis of mortality incidence","volume":"24","author":"Capra","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B122","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000521612","article-title":"Prediction of respiratory failure and mortality in COVID-19 patients using long pentraxin PTX3","volume":"14","author":"Hansen","year":"2022","journal-title":"J Innate Immun"},{"key":"B123","doi-asserted-by":"publisher","first-page":"110162","DOI":"10.1016\/j.isci.2024.110162","article-title":"sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID","volume":"27","author":"Hurler","year":"2024","journal-title":"iScience"},{"key":"B124","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semcdb.2016.07.026","article-title":"Humoral innate immunity at the crossroad between microbe and matrix recognition: The role of PTX3 in tissue damage","volume":"61","author":"Doni","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141268","article-title":"An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode","volume":"212","author":"Doni","year":"2015","journal-title":"J Exp Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02817","article-title":"Editorial: the role of pentraxins: from inflammation, tissue repair and immunity to biomarkers","volume":"10","author":"Bottazzi","year":"2019","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.03.007","article-title":"Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation","volume":"1862","author":"Bonacina","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B128","doi-asserted-by":"publisher","first-page":"116231","DOI":"10.1016\/j.bone.2021.116231","article-title":"PTX3 promotes osteogenic differentiation by triggering HA\/CD44\/FAK\/AKT positive feedback loop in an inflammatory environment","volume":"154","author":"Dong","year":"2022","journal-title":"Bone"},{"key":"B129","doi-asserted-by":"publisher","first-page":"117385","DOI":"10.1016\/j.bone.2024.117385","article-title":"PTX3-assembled pericellular hyaluronan matrix enhances endochondral ossification during fracture healing and heterotopic ossification","volume":"192","author":"Dong","year":"2025","journal-title":"Bone"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-021-02105-4","article-title":"Elevated ovarian pentraxin 3 in polycystic ovary syndrome","volume":"38","author":"Pan","year":"2021","journal-title":"J Assisted Reprod Genet"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02808","article-title":"The influence of pentraxin 3 on the ovarian function and its impact on fertility","volume":"9","author":"Camaioni","year":"2018","journal-title":"Front Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-948551","article-title":"Extracellular matrix of the cumulus-oocyte complex","volume":"24","author":"Russell","year":"2006","journal-title":"Semin Reprod Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.568154","article-title":"Incorporation of pentraxin 3 into hyaluronan matrices is tightly regulated and promotes matrix cross-linking","volume":"289","author":"Baranova","year":"2014","journal-title":"J Biol Chem"},{"key":"B134","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2014.81","article-title":"Extracellular pattern recognition molecules in health and diseases","volume":"12","author":"Zhang","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-005-7828-2","article-title":"Protective molecules\u2013C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity","volume":"25","author":"Kravitz","year":"2005","journal-title":"J Clin Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3433","article-title":"Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis","volume":"104","author":"Rusnati","year":"2004","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1705051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:20:29Z","timestamp":1765948829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1705051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":137,"alternative-id":["10.3389\/fimmu.2025.1705051"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1705051","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"article-number":"1705051"}}